Rutgers Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment. People in the News: Peer Schatz Board Appointments at Siemens, Centogene; More E. Coli Metabolic Gene Mutations Implicated in Antibiotic Resistance The mutations in these underappreciated noncanonical genes were overrepresented in the E. coli genomes, indicating they were clinically relevant. Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions. Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management. Aug 19, 2020 Rutgers Completes $44.4M Spinout of RUCDR Infinite Biologics Jul 29, 2020 Saliva Samples Slow to Catch On for Large-Scale Coronavirus Testing Premium Apr 29, 2020 COVID-19 Testing Could Get Boost From Alternative Sample Types Premium Apr 20, 2020 Addressing Coronavirus Testing Bottleneck, Scientists Turn to RNA-Extraction-Free PCR Apr 13, 2020 Rutgers Gets FDA EUA for Modified Thermo Fisher Coronavirus Assay for Use With Saliva Samples Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Jan 14, 2020 Rutgers Licenses Base Editing Tech to Horizon Discovery Nov 4, 2019 RCSB Protein Data Bank Lands $34.5M in Federal Grants Oct 14, 2019 CureDuchenne, UC Irvine, RUCDR Partner on Muscular Dystrophy Biobank Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Jan 3, 2019 Tumor Sequencing May Pick Up Mutations Caused by Coexistent Blood Disorder Nov 29, 2018 2018 GenomeWeb Salary Survey Jan 29, 2018 Rutgers Statistical Method Assesses LOH in Tumor Suppressor Genes, Supplements Sequencing Panels Premium Jun 30, 2017 Team Modifies Molecular Inversion Probes to Capture Kilobase-Sized DNA for Cloning, Sequencing Premium May 3, 2017 Tourette Disorder Risk Linked to Variants in Four Genes Jan 26, 2017 Phylogenomic Study Shows Utility of Ancient DNA Samples for Modern Research Jan 14, 2016 UPDATE: NHGRI Pledges $280M to Support Genomic Research on Common, Rare Diseases Oct 22, 2015 New Study Finds Three More CRISPR Proteins With Genome Editing Potential Oct 21, 2015 RUCDR Infinite Biologics Awarded $6M Grant to Manage NINDS Stem Cell Repository Jul 16, 2015 RUCDR, PreAnalytix, NuGen Validate RNA-seq Workflow for Human Whole Blood Samples Premium Load More Breaking News 23andMe to Acquire Telemedicine Platform Company Lemonaid Health for $400M in Cash, Stock UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.